Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials

Cancer - United States
doi 10.1002/cncr.31719
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Erratum: Jeter JM, Bowles TL, Curiel‐Lewandrowski C, Et Al. Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials. Cancer . 2019:125:18‐44.

Cancer
Cancer ResearchOncology
2019English

Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials

Clinics in Geriatric Medicine
GerontologyGeriatrics
2011English

Criteria for Implementation of Large and Multiagent Clinical Chemoprevention Trials

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2000English

Ethics in Clinical Trials : Ethical Standards in Phase 1 Trials of Neuroprotective Agents for Stroke Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1998English

Chemoprevention of Melanoma

Current Challenges in Personalized Cancer Medicine
2012English

Clinical Trials in Idiopathic Pulmonary Fibrosis: A Framework for Moving Forward

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2017English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy